Keltner Research Inc.

Depression Among a Sample of First-Time Adolescent and Adult Mothers
Journal of Child and Adolescent Psychiatric Nursing; 11/1/2009; 6560 words; ...6171.2009.00199.x © 2009 Wiley Periodicals, Inc. Research has shown that about one out of every 10 people in the...children are in the range of 40-50% (Lanzi, Pascoe, Keltner, & Ramey, 1999; Orr, James, Burns, &...

Raptor Pharmaceutical Expands Board of Directors.
Cancer Weekly; 10/13/2009; 1061 words; ...Association. Dr. Keltner has also authored several research publications on subjects...management programs. Dr. Keltner stated, "As a director...successful track record in research, development and commercialization...Raptor Pharmaceutical Inc., Solid Cancers...

Light Sciences Oncology Expands Development of Novel Targeted Drug Aptocine™ for Prostate Conditions With Start-Up of Phase 2 BPH Trial.
Cancer Weekly; 9/1/2009; 793 words; ...Light Sciences Oncology, Inc. (LSO) announced the...President and CEO, Llew Keltner, M.D., Ph.D...Keywords: Clinical Trial Research, Clinical Trials, Drug...Pharmaceuticals, Pre-Trials Research, Prostate Cancer, Prostatic...Light Sciences Oncology Inc. This article was prepared...

First Pediatric Patient Treated With Aptocine™, a Novel Light-Activated Drug, in Neurofibromatosis Study.
Cancer Weekly; 8/25/2009; 1016 words; Light Sciences Oncology, Inc. (LSO) announced the treatment...s President and CEO, Llew Keltner, M.D., Ph.D. The goal...Brain Carcinoma, Clinical Trial Research, Drug Development, Neuro...Treatment, Light Sciences Oncology Inc. This article was prepared...

First Pediatric Patient Treated With Aptocine(TM), a Novel Light-Activated Drug, in Neurofibromatosis Study.
PR Newswire; 8/12/2009; 1194 words; ...President and CEO, Llew Keltner, M.D., Ph.D...and pioneering major research initiatives, Children...worldwide. Its pediatric research program is among the...Light Sciences Oncology, Inc. Llew Keltner, M.D., Ph.D...